Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Methylprednisolone sodium succinate
Drug ID BADD_D01436
Description A water-soluble ester of methylprednisolone used for cardiac, allergic, and hypoxic emergencies.
Indications and Usage Adjunctive therapy for short-term administration in rheumatoid arthritis.
Marketing Status Prescription; Discontinued
ATC Code D07AA01; D10AA02; H02AB04
DrugBank ID DB14644
KEGG ID D00751
MeSH ID D008776
PubChem ID 23680530
TTD Drug ID Not Available
NDC Product Code 0009-0698; 0009-0047; 0009-0758; 63323-265; 68071-1792; 55150-263; 63323-258; 0009-0039; 55150-265; 55154-3941; 0009-0850; 50090-0271; 55154-3944; 63323-255; 71872-7061; 0143-9851; 55150-262; 0143-9850; 70518-2023; 71872-7232; 52584-039; 70518-3128; 0404-9958; 0009-0003; 55154-3939; 55154-3940; 55150-264; 0404-9957; 0009-0018; 52584-047
Synonyms Methylprednisolone Hemisuccinate | Hemisuccinate, Methylprednisolone | Methylprednisolone Succinate | Succinate, Methylprednisolone | Urbason-Soluble | UrbasonSoluble | Solu-Medrol | Solumedrol | A-MethaPred | Methylprednisolone Sodium Succinate | Sodium Succinate, Methylprednisolone | Methylprednisolone Hemisuccinate Monosodium Salt | 6 alpha-Methylprednisolone Sodium Hemisuccinate | Methylprednisolone Sodium Hemisuccinate | Sodium Hemisuccinate, Methylprednisolone
Chemical Information
Molecular Formula C26H33NaO8
CAS Registry Number 2375-03-3
SMILES CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)COC(=O)CCC(=O)[O-])O.[Na+]
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Thrombophlebitis24.01.02.001--Not Available
Urticaria23.04.02.001; 10.01.06.001--
Vasculitis24.05.02.001; 10.02.02.006--
Vertigo17.02.12.002; 04.04.01.003--
Weight increased13.15.01.006--
Oesophagitis ulcerative07.04.05.003--Not Available
Growth retardation15.03.01.006--
Affect lability19.04.01.001--Not Available
Hepatic enzyme increased13.03.01.019--Not Available
Skin test negative13.06.04.002--Not Available
Embolism24.01.01.009--
Lipid metabolism disorder14.08.04.003--Not Available
Mental disorder19.07.01.002--Not Available
Bladder dysfunction20.03.03.002--Not Available
Sperm concentration abnormal13.20.01.013--Not Available
Functional gastrointestinal disorder07.11.01.016--Not Available
The 4th Page    First    Pre   4    Total 4 Pages